ABSTRACT We report the isolation, spatial/temporal expression and gene disruption phenotype of the mouse ONT3 (mONT3) gene, which encodes a novel secreted signaling protein belonging to the Olfactomedin/Noelin/Tiarin family. During early embryogenesis, mONT3 is detected in the proximal region of the allantois on embryonic day (E) 7.25, in the lateral plate mesoderm on E 8.0 and in the CNS and heart on E 8.5. The homozygous mutant is born normal and fertile. For the expression pattern and loss-of-function analyses, we have successfully generated the LacZ-knockin targeting vector directly from BACs carrying mouse genomic fragments by combining in vivo and in vitro recombination techniques. This approach enables rapid and reproducible construction of the fully functional vectors within two weeks without the use of restriction enzyme digestion and ligation, or the use of PCR-amplification of large genomic fragments. In addition, this method is applicable to rapid generation of transgenic vectors, demonstrating its versatility in reverse genetic studies.
Introduction
Tissue interactions mediated by secreted signals play major roles in vertebrate embryogenesis. Recently, biochemical and molecular embryological studies have identified a novel secreted protein family, which includes bullfrog Olfactomedin, chicken Noelin and Xenopus Tiarin (Yokoe and Anholt, 1990; Barembaum et al., 2000; Tsuda et al., 2002) . Noelin is expressed in the neural crest of early chick embryos and controls the generations of migratory neural crest cells (Barembaum et al., 2000) . Tiarin is expressed in the non-neural ectoderm flanking the Xenopus neural plate and exhibits potent dorsalizing activities on developing central nervous system (CNS) tissues (Tsuda et al., 2002) .
To further understand the roles of the Olfactomedin/Noelin/ Tiarin (ONT) family factors, we have searched for other members of the ONT family expressed in chick and mouse embryos. Chick ONT1 (cONT1 ) has been isolated by the degenerative PCR approach and is expressed in various tissues of the early chick embryo (M.S., M.I., M.K., Y.S., manuscript in preparation). Using the sequence information of cONT1, we have identified another ONT -related gene expressed in the mouse embryo, named mouse ONT3 (mONT3 ). In this study, we report the isolation and cONT1. The deduced protein of mONT3 consists of 406 amino acid residues with a putative signal peptide at the N-terminus, a coiled-coil domain in the middle and an olfactomedin-like domain at the C-terminus (Fig. 1B) . These domains are highly conserved in the rat and human counterparts (Fig. 1B, C) . According to the genomic database, the mONT3 gene is located on mouse chromosome 3F2.2 and contains three exons spanning 2549 bp (Fig. 2C) .
To understand the in vivo expression pattern and requirement of mONT3, we generated LacZ-knock-in mice by gene targeting at the mONT3 locus. To maximize speed and simplicity and to minimize the risk of mutation, we have tested a strategy of generating gene-targeting vectors by combining in vivo recombination with in vitro recombination. For the sake of versatility, we use commercial kits for these recombinations: the Red/ET cloning technology (Gene Bridges GmbH) for 'in vivo ' subcloning of 5' and 3' genomic fragments from BACs ( Fig. 2A ) and the Multisite GATEWAY cloning system for 'in vitro ' assembling of genomic fragments and a universal marker cassette into a destination vector (Fig. 2B) . In this report, the combination strategy for vector construction using the Red/ET and GATEWAY systems is hereafter referred to as EG construction (ET and GATEWAY).
To start the vector construction, we first prepared the linear Entry clone vector backbones by using PCR for the 5' and 3' fragments (an Entry clone vector is a carrier plasmid of the insert for in vitro recombination). We designed PCR primers that carried A phylogenetic tree generated by ClustalW. The N-J tree with branch length program was selected. Source for sequences was as follows: amassin (accession number NM_214633), GW112 (accession number NM_006418), Myocilin (accession number NM_000261), cNoelin1 (accession number NM_204767), mNoelin1 (accession number NM_019498) and xNoelin1 (accession number AY071869), olfactomedin (accession number L13595), hONT2 (accession number NM_198474), mONT2 (accession number NM_172907), rONT2 (accession number NM_001013192), hONT3 (accession number NM_020190), mONT3 (accession number NM_133859), rONT3 (accession number XM_227535), Tiarin (accession number AB075925 appropriate att sites for Multisite GATEWAY recombination and short genomic sequences for Red/ET-mediated homologous recombination at corresponding ends ( Fig. 2A, step I ). In parallel, E. coli cells with a BAC clone containing the mONT3 gene (purchased from BACPAC Resources Center) were transformed with pSC101-BAD-gbaA that encoded proteins necessary for Red/ET recombination ( Fig. 2A, To confirm the correct integration of the 3' and 5' arms, DNA was prepared, cut with EcoRV and hybridized with 3' or 5' probes, respectively. Results of 3' probe hybridized with the DNA from recombinant ES cells and 5' probe hybridized with the DNA from mice are presented. (E) PCR genotyping of each allele. Genomic DNA was prepared from the tails of wild-type, heterozygous and homozygous mice. The DNA was amplified by PCR with allele-specific primers to detect the wild-type allele (389 bp; mONT3-5'A and mONT3-3'A) and the mutant allele (558 bp; mONT3-5'A and mONT3-LA). (Table 1) . We next applied the targeting vector to homologous recombination in the ES cells. We observed proper homologous recombination in 23/96 revertant ES cells (Fig. 2D and data not shown) and generated chimera mice with the knock-in ES cells. Genotyping of the knock-in mice was done by Southern blot and/or PCR (Fig. 2D, E and data not shown) . To analyze the expression pattern of mONT3, heterozygous embryos were stained with Xgal solution. LacZ signals were first detected on E7.25 in the proximal region of the allantois (Fig. 3A, F) and expanded to the presumptive lateral plate mesoderm by E8.0 (Fig. 3B, G) . The staining was also observed in the midbrain-hindbrain boundary, rhombomere 3 and 5 of the hindbrain, the neural tube and the heart on E8.5 (Fig. 3C, H ) and in the otic vesicles on E9.5 (Fig. 3D,  I ). On E10.5, we observed LacZ expression in the lens (Fig. 3E , J, K), neural tube, roof plate of the neural tube posterior to the forelimb level (Fig. 3E , J, L), ventral portion of the diencephalon and midbrain, branchial arches and mesenchymal tissues dorsal to the telencephalon (Fig. 3E, J) . These expression patterns were reproduced in the knock-in mice from at least two independent ES cell lines. Whole-mount in situ hybridization revealed consistent expression patterns (data not shown).
Next, we intercrossed heterozygotes to evaluate homozygous phenotypes. Genotyping analysis showed that litters of all three genotypes were born according to the Mendelian ratio (Table 2) . Homozygotes were indistinguishable from wild-type and heterozygous mice in external appearance, growth and behavior. Both male and female were fertile and produced a normal litter size (data not shown). These results demonstrate that mONT3 (zygotic and maternal) is dispensable for normal embryogenesis.
As shown above, the EG construction approach works satis-(Nagai et al., 2002)) widely in the developing CNS. A recent report has demonstrated that mSox3 enhancers are clustered in a relatively small genomic region adjacent to the coding region (Brunelli et al., 2003) . This situation is in contrast to that of chick Sox2 enhancers, which are dispersed in long genomic areas (spanning over 50 Kb; Uchikawa et al., 2003) . We used 3.3 Kb of 5' and 3.9 Kb of 3' fragments containing sufficient neural-specific enhancers according to the previous report (Fig. 4A ). In the subcloning of these fragments by the in vivo Red/ET reaction, (C,H) At E8.5, the staining was observed in the midbrain-hindbrain boundary (arrowheads), rhombomere 3 and 5 (asterisks), the neural tube (small gray arrow), the lateral plate mesoderm and the heart. (D, I) At E9.5, the staining was also observed in the otic vesicles (small arrows). (E,J) At E10.5, the staining was observed in the mesenchymal tissues dorsa to the telencephalon (bracket), lens, ventral portion of the diencephalons and midbrain, branchial arches and roof plate of the neural tube (small arrowheads in E). (K,L) Sections of the eye and trunk regions of the E10.5 embryo as indicated in (J). DA, dorsal aorta; FP, floor plate; RP, roof plate; l, lens vesicle; SE, surface ectoderm. factorily for the construction of gene targeting vectors from BACs. This prompted us to ask whether this technique is applicable to the generation of transgenic vectors. Until recently, the bottleneck for in vivo analyses of region-specific enhancers has been the production of transgenic mice and expansion of the colonies. The recent invention of the in ovo chick electroporation method has provided an alternative approach that remarkably accelerates the finding of the regulatory regions working in the embryo (Uchikawa et al., 2003) . In this approach, the rate-limiting step is shifted to the construction step of transgenic vectors. To test the compatibility of our strategy, we generated a transgenic vector that drives the expression of a fluorescence protein (in this case, Venus GFP correct recombination was observed in 8/15 for the 5' Entry clone and 1/3 for the 3' Entry clone. The in vitro LR recombination step was successful in 7/8 ( Table 1) .
EFFICIENCY OF RECOMBINATION REACTIONS
The resulting transgenic vector was tested by using the in ovo electroporation technique. We introduced the vector DNA into the epiblast of HH4 chick embryos and cultured them in the modified EC cultures (Chapman et al., 2001 ). We did not observe any strong fluorescence until HH6 (Fig. 4B ), while we observed GFP expression driven by the control CMV promoter as early as HH 5 (data not shown). At HH9, we observed strong fluorescence restricted to the neural tube (signals at the hindbrain region were relatively weak; Fig. 4C , E). We also saw GFP expression in migrating neural crest cells in the hindbrain region ( Fig. 4E ). At HH13, we observed GFP signals in the optic and otic vesicles, branchial arches, forebrain, midbrain and spinal cord (Fig. 4D, F) . These expression patterns are largely consistent with LacZ expression in the transgenic mouse and Xenopus embryos (Brunelli et al., 2003) as well as Sox3 mRNA distribution in the chick (AbuElmagd et al., 2001). These results suggest that the regulatory system underlying Sox3 expression is conserved between chick and mice and showed that this Sox3 transgenic vector is useful for driving the expression of a gene of interest in a large region of the neural tissues after HH9, since a one-step LR reaction can easily replace the Venus GFP portion with any other cDNA.
Discussion
In this study, we have performed the expression pattern and gene disruption analyses of mONT3. The ONT family is a relatively new group of secreted signals that seem to play regulatory roles in vertebrate embryogenesis (Barembaum et al., 2000; Tsuda et al., 2002) . However, only gain-of-function studies on the family members have been so far reported while knowledge on the in vivo roles of endogenous ONT factors is still limited. As shown in figure 3, intriguing expression patterns of mONT3 are observed in mouse embryos. Our preliminary gain-of-function study has shown that mONT3 exhibits a dorsalizing effect, as shown for xTiarin, when overexpressed in Xenopus embryos. While overexpression of mONT3 at a low dose (500 pg mRNA per cell: animal blastomere injection at the eight cell stage) does not induce expansion of the dorsal CNS markers Zic-r1 (n=12) and Pax3 (n=15), a high dose injection of mONT3 (2000pg) induces moderate expansion of the expression domains of these dorsal marker genes (40.9%, n=22 for Zic-r1; 31.6%, n=19 for Pax3; Fig.  5 ), suggesting the mONT3 has a weak dorsalizing activity in the context of Xenopus ectodermal patterning. In contrast, homozygous mONT3 mutants are viable, apparently normal (including TABLE 2 development and basic functions of the brain) and fertile. These observations suggest the possibility that the mONT3 gene function is dispensable and possibly compensated by other family genes. In future, the generation and detailed analyses of individual and compound KO mice of other ONT family members are required for understanding the exact in vivo roles of this gene family during embryogenesis. In addition, we have explored a rapid construction method for the generation of the target vector. The recent introduction of the total genomic sequence database has highlighted the promise for high-throughput analysis in functional genomics to elucidate the in vivo functions of gene networks. Although transgenic and gene targeting analyses are key approaches in the study of large-scale reverse genetics, they require elaborate processes of isolating and subcloning large genomic fragments. The large collection of mouse genomic BAC clones is an attractive source for genomic fragment isolation. However, the handling of BACs is technically demanding and the conventional digestion/subcloning processes are time-consuming and often problematic.
MONT3 GENOTYPES OF THE F2 PROGENY FROM F1 HETEROZYGOTE INTERCROSS
This study has shown the usefulness of the 'EG construction' approach for generating transgenic and targeting constructs. This strategy takes advantage of the two recombination systems. First, by using the Red α/β-based in vivo recombination, one can isolate genomic fragments from the large collection of BAC libraries without the handling of BAC DNAs or the use of PCR, which may cause mutations. Second, by using the in vitro recombination, one can perform simultaneous directional subcloning of three DNA fragments (containing 5', 3' and marker insert fragments) into a targeting vector in a seamless manner. Furthermore, the same vectors containing the 5' and 3' genomic fragments can be used for generating constructs for KO, knock-in, conditional KO, transgenic and promoter analysis studies by utilizing ready-made universal marker cassettes (e.g. drug selection and GFP markers). By combining two types of recombination techniques, this strategy provides satisfactory speed, efficiency and reproducibility, as demonstrated in this study. In addition to the mONT3 and Sox3 constructs, we have applied the EG construction to the generation of a GFP transgenic vector carrying the 8 Kb 5' fragment and 5 Kb 3' fragment of the Foxd3 gene. In this case, 1/94 for the 5' Entry clone, 1/16 for the 3' Entry clone and 5/5 of the transgenic vector underwent correct recombination (Table 1) . Taken together, at all recombination steps involving 3-8 Kb genomic fragments (except for the Red/ET step of the long 5' Foxd3 fragment), correct plasmids were obtained by DNA preparation with less than 24 colony pick-ups. This means that, in most cases, the desired construction can be obtained within a single trial of the standard mini-prep procedure using a typical bench-top centrifuge (18-24 slots). Similar efficiencies were observed in the construction of three other targeting vectors (MI, MK and YS, unpublished observations). In summary, we propose EG construction as a versatile and practical approach for constructing targeting and transgenic vectors. A detailed step-by-step protocol for practical use of the EG construction is provided in the Appendix to this paper.
Materials and Methods

Construction of the 5', 3' and reporter Entry clone plasmids
Red/ET cloning was performed according to the manufacturer's instructions (Gene Bridges GmbH, Germany) and the procedures described previously (Testa et al., 2003) with some modifications. To combine with the Multisite GATEWAY technology (Invitrogen Corp., Carlsbad, CA USA), we first created linear 5' and 3' Entry vector backbones that have appropriate att sites and short sequences of homologous recombination regions (blue and checked boxes in Fig. 2A ) by using PCR. Each PCR primer (A, B, C and D in Fig. 2A ) was designed to include 50 to 54 nucleotides of homologous regions in each genomic sequence, followed by 27 or 28 nucleotides of GATEWAY vector sequences at the 3' end (underlined). The templates and primers were: 
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ttgcctcaggtacaacttttctatacaaagttggcattat-3' B: 5'-gaaagaggccgaatgcacacactcctctggccccactt aaggctgccatggcaagtttgtacaaaaaagttgaacgag-3' < mONT3-3' Entry vector > Template: pDONR-P2RP3 (linearized with BamH1) C: 5'-caagtccctcacctctaaggcagctagtcggcgttcc atgtactccacaaccactttgtacaagaaagttgaacgag-3' D: 5'-aacactcctccttttgtctgtctttcttctctccacagg cagagctgctccaactttattatacaaagttggcattat-3' BAC-containing E. coli was identified by the alignment of BAC end sequences in the NCBI database and purchased from BACPAC Resources Center (Children's Hospital of Oakland Research Institute, URL http://bacpac.chori.org/). They were transformed with pSC101-BAD-gbaA according to the standard procedures. Cells were prepared for electroporation after inducing expression of recombination proteins. Linear 5' and 3' Entry vector generated formerly was transfected individually into the E. coli carrying the BAC clone. Entry clones containing attflanked genomic fragments were generated by Red/ET recombination. Proper recombination was confirmed by restriction enzyme mapping.
For a transgenic construct, a DNA fragment containing the Venus gene flanked with att sites was amplified by PCR from Venus/pCS2 (Nagai et al., 2002).
[primers att-Venus-: ggggacaagtttgtacaaaaaagcaggcttcatggtgagcaagggcgaggagctgttcacc att-Venus-R: ggggaccactttgtacaagaaagctgggtttacttgtacagctcgtccatgccgagagt] and subcloned into a pDONR 221 vector (named Venus-in-ENTR) by using BP clonase (Invitrogen). For a targeting vector, the NLS-LacZ-pA cassette from BAT-gal (Maretto et al., 2003) was subcloned into a loxPflanked PGK-neo vector using the conventional method and the NLSLacZ-pA-loxP-PGK-neo-loxP cassette was subcloned into pDONR221 by Red/ET-cloning (named nBLUEneo in ENTR).
Construction of DT-A (B.DEST)
For targeting vector construction, we made a Destination vector, pDT-A(B.DEST), which contains a DT-A cassette and a linearizing site. First, att -flanked ccdB and chloramphenicol resistance gene cassette 3' to the linearizing site was amplified from the pDEST(R4-R3) vector (Invitrogen) using the following PCR primers: [Forward: ataagaatgggcccggcgcgccttaattaaggccggccgttt aaacgcggccgcatttaaatcaggaaacagctatgac and Reverse: ccgctcgaggtaaaacgacggccag] and cut with PspOMI and XhoI. Second, pMCDT-A(A+T/pau), which contains diphtheria toxin A fragment gene with MC1 promoter for the negative selection of homologous recombinant (Yagi et al., 1993b) , was cut with NotI and XhoI and ligated with the PCR fragment. The linearizing site contains sequences recognized with restriction enzymes of AscI, PacI, FseI, PmeI, NotI and SwaI (underlined).
Generation of the transgenic construct and the targeting vector
To make three DNA fragments subcloned directionally into one Destination vector, we used the Multisite GATEWAY Three-fragment Vector Construction Kit (Invitrogen). Two Entry clone plasmids carrying 5' and 3' genomic fragments were prepared from each recombinant E. coli using QIAprep Spin Miniprep Kit (QIAGEN). Following the manufacture's protocol, we used these Entry clone plasmids for LR plus recombination reactions with the Venus in ENTR and a pDEST(R4-R3) for the transgenic construct and with the nBLUEneo and the DT-A(B.DEST) for the targeting vector.
Establishment of mONT3 targeted mice and X-gal staining analysis
The targeting vector was transfected to TT2 embryonic stem cells (Yagi et al., 1993a) and homologous recombinant ES cells were primary screened by PCR with neoC2 primer: (5'-GCCTGCTTGCCGAATATCATGGTGGAAAAT-3') and Select5 primer (5'-ATTAAGTGGCGCGGACAAGCACTTC-3') and confirmed by Southern blot analysis. After electroporation to TT2 ES cells, 23 of 96 clones were PCR positive. We selected 13 clones for Southern blot analysis and confirmed that all of them had correct recombination. Recombinant ES cells were injected into an eight-cell embryo of CD-1 mice. We obtained germline chimeras from three independent recombinants and observed no differences in the phenotypes among these lines.
Embryos were stained with X-gal as described in Kimura et al. (Kimura  et al., 1997) .
PCR-genotyping of mice
Genomic DNA was isolated from tails or yolk sacs. They were digested overnight at 55ºC in 100 mM Tris-HCl pH 8.0, 5 mM EDTA, 0.2% SDS and 200 mM NaCl in the presence of 100 µg/ml of Proteinase K. Samples were then boiled for 15 minutes, diluted 5 times with sterile water, spun at 13000 rpm for 15 minutes to pellet the debris. 1 µl of the supernatant was subjected to PCR. Primers were designed against the sequence 5' and 3' to the ATG start codon of mONT3 (mONT3-5'A and mONT3-3'A, respectively) and against the sequence of β-galactosidase (mONT3-LA). The primers were: mONT3-5'A: AAAGAGGCCGAATGCACACACTCCT mONT3-3'A: GACTCTCATTTCCCCTGCCCCCTTA mONT3-LA: GCACCACAGATGAAACGCCGAGTTA
Electroporation to chick embryos
Chick electroporation was performed as described previously (Uchikawa et al., 2003) . After vector DNA was introduced by electroporation, the embryos were cultured on an agar albumen plate according to the EC method (Chapman et al., 2001 ) with some modification. We placed the embryos with the dorsal side up, overlaid with a drop of liquid albumen and incubated them at 37ºC. 
Experimental Procedures
Primer design
(Note that this protocol is for replacing the gene with the marker gene casette at the 1st ATG to the marker gene.)
1)
Prepare the sequence data of the gene of interest.
2)
To find the position of the 1st exon on a chromosome and exon-intron structure of the gene, submit the sequence data to NCBI mouse genomic BLAST (http://www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html).
3) Click 'Genome View' and find the position of the gene. To display the 'Map View,' click the chromosome number.
4)
Click 'Maps & Option.' Add 'BES_Clone' to 'Maps displayed' and move it down. Click 'apply' to display the names of the BAC clones that contain the gene. 
Confirmation of BAC clones
(Note that the following procedure is for the BAC clones derived from the RPCI-23 library. If you use another library, the antibiotics should be changed accordingly.)
14) The BAC clones derived from the RPCI-23 library are purchased from the BACPAC Resource Center and sent as LB stab stocks. When they arrive, make glycerol stocks and ensure that the clones include the gene of interest by PCR using gene-specific primers.
BAC clone preparation
We routinely use a QIAprep Spin Miniprep Kit. The concentrations of the eluted BAC DNA solutions are low, but sufficient for use as PCR templates. Prepare cultured E. coli at STEP 17. At the elution step, apply 100 µl of prewarmed (65ºC) Buffer EB to the filter, leave for 1 min at RT and spin at 13,000 rpm for 1 min. If you apply 10 µl of the eluted solution on agarose gel, you can usually observe a faint band (about 10 ng)).
Clone check by PCR
i) Design the PCR primers around the 1st ATG. (Later, the 5' primer is also used as a sequence primer to check the correct recombination of the final construct.
We routinely use the 'Primer3 program' iii) PCR conditions 94ºC hold (Easy hot start) 94ºC for 5 min {94ºC for 30 sec / * XºC for 2 sec / 74ºC for 30 sec} x 35 74ºC for 5 min 4ºC for ∞ iv) Apply 5 µl of PCR product on agarose gel and check the correct amplification.
*We routinely perform touchdown PCR. During the initial ten cycles, the annealing temperature is decreased from 62ºC to 57ºC.
Then, we perform PCR for 25 cycles with an annealing temperature of 57ºC.
Preparation of electrocompetent cells (for 5 tubes)
[Reagents]
LB medium 10 ml x the number of BAC clones 10% Glycerol/DW LB plate with 20 µg/ml of chloramphenicol (x the number of BAC clones)
We routinely prepare antibiotic-free LB plates (25 ml of LB in a 9-cm Petri dish) and spread 5 µl of chloramphenicol (100 mg/ml) diluted with 45 µl of DW and dry briefly just before use (final concentration should be about 20 µg/ml).
Chloramphenicol (100 mg/ml)
Day -1 15) Streak the E. coli containing BAC clone on an LB plate (+Cm: final 20 µg/ml (1/5000 dilution)) and incubate at 37ºC overnight.
Day 0
16) Pick a single colony and inoculate it into 5 ml of LB medium (+Cm: final 20 µg/ml). Incubate at 37ºC overnight.
Day 1
17) Make glycerol stocks. (Mix 100 µl of the culture and 100 µl of 60% glycerol/DW.) Transfer 3 ml of the culture for the mini-prep (STEP 14). 48) Spread 100 µl of the culture on an LB plate (+Kan), spin the rest at 11,000 rpm for 30 sec, resuspend in 100 µl and plate that on another LB plate (+Kan).
Electroporation for ET cloning
49) Incubate at 37ºC overnight. 
59)
Add 2 µl of Proteinase K and incubate at 37ºC for 10 min.
Desalt (by QIAGEN PCR purification kit) 60) Add 30 µl of DW (up to 50 µl).
61)
Add 250 µl of Buffer PB, apply to the spin column and spin at 13,000 rpm x 1 min. Discard the flow-throw.
